X
Syncona rakes in the cash as Bracco buys Blue Earth for $450m
https://pharmaphorum.com/news/syncona-rakes-in-the-cash-as-bracco-buys-blue-earth-for-450m/
diagnostics
10th Annual Pharma Market Research Conference
The best industry assembly of market researchers.
Breath Biopsy company adds new investor to $15m fundraising
Owlstone Medical, the innovative company which promises to revolutionise the diagnosis of cancer by simply analysing a patient’s breath has been given a major funding boost.
The future of diagnostics: personal genetic services
With genetic analysis and diagnostic tests now available via mail order, how will this trend towards the proactive consumer impact the evolution of health management?
Angle produces new data backing liquid biopsy in cancer
Angle hopes Parsortix will be first approved cell-based liquid biopsy.
Major trial for potential ‘game changer’ cancer diagnostic begins
Breath Biopsy will be tested in its ability to detect several cancers earlier than traditional methods.